Please provide your email address to receive an email when new articles are posted on . “In type 2 diabetes, previous cohort studies found a doubled risk for diabetic foot ulcers or amputations in ...
ELX-02 treatment improved podocyte foot process effacement in all three patients by an average of 60% based on a blinded kidney biopsy analysis by NIPOKA GmbH Biopsy results support clinical benefit ...
Kidney morphology improved in all three patients with protein re-expression consistent with disease regression in its Phase 2 open-label clinical trial of ELX-02 for the treatment of Alport Syndrome ...
Please provide your email address to receive an email when new articles are posted on . Patients who received foot and ankle care had an 11% lower likelihood of death. These patients had a 9% lower ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results